Related Experiment Video
Updated: Feb 6, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
MiR-145 affected the circular RNA expression in prostate cancer LNCaP cells
Jin-Hua He1, Ze-Ping Han1, Jia-Bin Zhou1
1Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, Guangdong, China.
Abstract:
Recent evidence has demonstrated that circular RNAs (circRNAs) played crucial roles in fine-tuning the levels of gene expression by sequestering the corresponding microRNA (miRNAs). Their interaction with disease-associated miRNAs indicates that circRNAs are important for the development of disease, and miR-145 has been previously shown to have antitumor effect in prostate cancer. In the current study, we successfully established the miR-145-overexpressed prostate cancer LNCaP cells (LNCaP-miR-145) using lentiviral vectors. LNCaP cells expressing the empty vector (LNCaP-NC) were used as the negative control. The circRNA expression in LNCaP-miR-145 cells was detected by microarray analysis, and the miRNA targets of circRNAs were predicted using the bioinformatics software TargetScan and miRanda. Quantitative reverse transcription polymerase chain reaction was used to detect the expression levels of circRNAs in the prostate cancer tissue, nonmalignant tissue, LNCaP-miR-145 cells, and LNCaP-NC cells. The interaction of miRNA and circRNA was further confirmed by the dual-luciferase reporter assay. A total of 267 and 149 circRNAs were significantly up- and downregulated in LNCaP-miR-145 cells, respectively. hsa_circRNA_101981, hsa_circRNA_101996 and hsa_circRNA_09142 were the 3 circRNAs that interacted with hsa-miR-145-5p; hsa_circRNA_008068 and hsa_circRNA_406557 were the 2 circRNAs that interacted with hsa-miR-145-3p. Most of the circRNAs corresponded to the protein-coding exons. The expression levels of hsa_circRNA_101981, hsa_circRNA_00806, and hsa_circRNA_406557 were upregulated in the LNCaP-miR-145 cells, but downregulated in the prostate cancer tissue. In contrast, the expression levels of hsa_circRNA_101996 and hsa_circRNA_091420 were downregulated in the LNCaP-miR-145 cells, but upregulated in the prostate cancer tissue. Moreover, miR-145-5P might regulate the expression of hsa_circRNA_101981, hsa_circRNA_101996, and hsa_circRNA_09142, while miR-145-3P might regulate the expression of hsa_circRNA_008068 and hsa_circRNA_406557. Overexpression of miR-145 promoted the expression of hsa_circRNA_101981, hsa_circRNA_008068, and hsa_circRNA_406557 but suppressed the expressions of hsa_circRNA_101996 and hsa_circRNA_091420 in LNCaP cells. The results from the current study should give us a clue to clarify the tumor suppressive effect of miR-145.
Insights
Circular RNAs (circRNAs) interact with microRNAs (miRNAs) to regulate gene expression. This study identified specific circRNAs interacting with miR-145, revealing their altered expression in prostate cancer and potential roles in miR-145
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) are key regulators of gene expression by sequestering microRNAs (miRNAs).
- MiR-145 exhibits antitumor properties in prostate cancer.
- Understanding circRNA-miRNA interactions is crucial for disease development insights.
Purpose of the Study:
- To investigate the circRNA expression profile in miR-145-overexpressed prostate cancer cells.
- To identify specific circRNAs that interact with miR-145.
- To explore the relationship between circRNA expression and prostate cancer.
Main Methods:
- Establishment of miR-145-overexpressed LNCaP cells (LNCaP-miR-145) using lentiviral vectors.
- Microarray analysis to detect circRNA expression.
- Bioinformatic prediction (TargetScan, miRanda) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) for circRNA-miRNA interactions and expression levels.
- Dual-luciferase reporter assay to confirm interactions.
Main Results:
- A total of 267 and 149 circRNAs were significantly upregulated and downregulated, respectively, in LNCaP-miR-145 cells.
- Specific circRNAs (hsa_circRNA_101981, hsa_circRNA_101996, hsa_circRNA_09142) interacted with hsa-miR-145-5p, and others (hsa_circRNA_008068, hsa_circRNA_406557) interacted with hsa-miR-145-3p.
- Differential expression of identified circRNAs was observed between LNCaP-miR-145 cells and prostate cancer tissues.
- Overexpression of miR-145 promoted certain circRNAs (hsa_circRNA_101981, hsa_circRNA_008068, hsa_circRNA_406557) while suppressing others (hsa_circRNA_101996, hsa_circRNA_091420) in LNCaP cells.
Conclusions:
- This study identified novel circRNAs that interact with miR-145 in prostate cancer cells.
- The findings suggest that circRNAs play a role in the antitumor effects of miR-145.
- These circRNA-miRNA interactions provide potential targets for understanding and treating prostate cancer.
Related Concept Videos
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Deformation in a Circular Shaft
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

